KevinGreggBillingsleyMDMBA
General Surgery • New Haven, CTHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Chief Medical Officer, Yale Cancer Center Professor of Surgery, Division of Surgical Oncology School of Medicine Yale School of Medicine
Dr. Billingsley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St. North Pavilion
Smilow Cancer Hospital, 15 th Floor, Suite 300
New Haven, CT 06510Phone+1 203-200-3168
Summary
- I am gastrointestinal surgical oncologist with a primary focus on the multidisciplinary treatment of patients with tumors of the liver, bile ducts and pancreas.
In addition to my clinical practice I am the CMO of the Yale Cancer Center
My research involves clinical and outcome studies in the hepatobiliary and pancreatic cancer. I have a particular interest in developing novel approaches to the treatment of liver metastases.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
Oregon Health & Science University (OHSU Health)Residency, Surgery, 1989 - 1996
National Cancer InstituteFellowship, Senior Staff Fellow, Surgery Branch, 1992 - 1994
Johns Hopkins University School of MedicineClass of 1989
Certifications & Licensure
CT State Medical License 2019 - 2025
OR State Medical License 1990 - 2025
WA State Medical License 1998 - 2021
MD State Medical License 1992 - 1994- American Board of Surgery Surgery
Awards, Honors, & Recognition
- James IV Fellow James IV Association, 2007
- America's Top Doctors Castle Connolly, 2011-2014
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver Start of enrollment: 2001 May 01
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 1 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01 - Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, Christopher L Corless, Charles D Blanke
Journal of Surgical Oncology. 2024-07-01 - Reasonable expansion of surgical candidates for HCC treatment.Samuel D Butensky, Kevin G Billingsley, Sajid A Khan
Clinical Liver Disease. 2024-05-08
Press Mentions
Patrick a. Kenney, MD, Appointed Medical Director, Smilow Cancer Hospital Care Center at Greenwich HospitalJanuary 13th, 2023- Coping with Cancer and COVID During the HolidaysDecember 25th, 2021
- How Patients with Cancer Can Navigate COVID-19 for the HolidaysDecember 20th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
